<?xml version="1.0" encoding="UTF-8"?>
<list list-type="bullet">
 <list-item>
  <p>Clear information should be given to patients and caregivers to avoid panic and mismanagement.</p>
 </list-item>
 <list-item>
  <p>Application of teledermatology resources for close follow up and monitoring of the patients to minimize patientâ€™s referral to healthcare centers could be very helpful (
   <xref rid="B31" ref-type="bibr">31</xref>). 
  </p>
 </list-item>
 <list-item>
  <p>Patients should be followed at regular intervals with a focus on screening the patients for symptoms of COVID-19.</p>
 </list-item>
 <list-item>
  <p>Healthcare professionals who are in close contact with these patients should be monitored and be vigilant in using recommended precautions and proper ethical teledermatology practice (
   <xref rid="B31" ref-type="bibr">31</xref>). 
  </p>
 </list-item>
 <list-item>
  <p>Psychological tolerance of patients during quarantine, especially in those who receive high doses of corticosteroids leading to mood swings, should be monitored and possible coping strategies should be discussed.</p>
 </list-item>
 <list-item>
  <p>The possible flare of the underlying condition should be seriously considered in cases of drug discontinuation without reasonable indication.</p>
 </list-item>
 <list-item>
  <p>Patients with milder disease can be treated less aggressively with local steroids (topical or intralesional), dapsone and doxycycline (
   <xref rid="B7" ref-type="bibr">7</xref>). 
  </p>
 </list-item>
 <list-item>
  <p>If indicated, it is better to administer RTX in an infusion center outside the hospitals that are treating COVID-19 patients.</p>
 </list-item>
 <list-item>
  <p>With regard to the current and emerging treatments of COVID-19 such as anti-malaria drugs (
   <xref rid="B32" ref-type="bibr">32</xref>) and IL6 inhibitors (
   <xref rid="B33" ref-type="bibr">33</xref>), dermatologists have to consider possible drug interactions or more rigorous prophylactic strategies in PV patients, respectively.
  </p>
 </list-item>
</list>
